TY - JOUR
T1 - Mechanisms of immunity in hydatid disease
T2 - Implications for vaccine development
AU - Zhang, Wenbao
AU - Ross, Allen G.
AU - McManus, Donald P.
PY - 2008/11/15
Y1 - 2008/11/15
N2 - The Echinococcus
organisms, the cause of echinococcosis (hydatid disease), are parasitic
helminths with life cycles involving a carnivorous definitive host
(usually dog or fox) and an intermediate host (human, ungulate, or
rodent). They are complex multicellular pathogens that, despite being
under constant barrage by the immune system, are able to modulate
antiparasite immune responses and persist and flourish in their
mammalian hosts. Understanding how the immune system deals with these
parasites is a major challenge. Recent application of modern molecular
and immunological approaches has revealed insights on the nature of
immune responses generated during the course of hydatid infection,
although many aspects of the Echinococcus-host interplay remain
unexplored. This review summarizes current understanding of the
immunology of echinococcosis, indicates areas where information is
lacking, and shows how knowledge of host protective immunity has been
translated into the design and development of anti-Echinococcus vaccines for application in intermediate hosts.
Hydatid disease is a chronic, cyst-forming,
parasitic helminthic disease of human beings as well as domestic and
wild animals. It is caused by infection with the larval (metacestode)
stages of dog/fox tapeworms (cestodes) belonging to the genus Echinococcus
(family Taeniidae) and is also referred to as echinococcosis. The two
major species of medical and public health importance are Echinococcus granulosus and Echinococcus multilocularis, which cause cystic echinococcosis (CE)3
and alveolar echinococcosis (AE), respectively. Human cystic
echinococcosis is the most common presentation and probably accounts for
>95% of the estimated 3 million global cases, with human alveolar
echinococcosis causing ∼0.3–0.5 million cases (all in the Northern
Hemisphere).The life cycle of the two tapeworms is shown in Fig. 1⇓. Hydatid cysts of E. granulosus
develop in internal organs (mainly liver and lungs) of humans and
intermediate hosts (herbivores such as sheep, horses, cattle, pigs,
goats, and camels) as unilocular fluid-filled bladders. These consist of
two parasite-derived layers, an inner nucleated germinal layer and an
outer acellular laminated layer surrounded by a host-produced fibrous
capsule. Brood capsules and protoscoleces bud off from the germinal
membrane. Definitive hosts are carnivores such as dogs, wolves, and
foxes. Sexual maturity of adult E. granulosus occurs in the
host small intestine within 4–5 wk of ingesting offal containing viable
protoscoleces. Gravid proglottids or released eggs are shed in the feces
and, following their ingestion by a human or ungulate host, an
oncosphere larva is released that penetrates the intestinal epithelium
into the lamina propria. This is then transported passively through
blood or lymph to the target organs where it develops into a hydatid
cyst.
AB - The Echinococcus
organisms, the cause of echinococcosis (hydatid disease), are parasitic
helminths with life cycles involving a carnivorous definitive host
(usually dog or fox) and an intermediate host (human, ungulate, or
rodent). They are complex multicellular pathogens that, despite being
under constant barrage by the immune system, are able to modulate
antiparasite immune responses and persist and flourish in their
mammalian hosts. Understanding how the immune system deals with these
parasites is a major challenge. Recent application of modern molecular
and immunological approaches has revealed insights on the nature of
immune responses generated during the course of hydatid infection,
although many aspects of the Echinococcus-host interplay remain
unexplored. This review summarizes current understanding of the
immunology of echinococcosis, indicates areas where information is
lacking, and shows how knowledge of host protective immunity has been
translated into the design and development of anti-Echinococcus vaccines for application in intermediate hosts.
Hydatid disease is a chronic, cyst-forming,
parasitic helminthic disease of human beings as well as domestic and
wild animals. It is caused by infection with the larval (metacestode)
stages of dog/fox tapeworms (cestodes) belonging to the genus Echinococcus
(family Taeniidae) and is also referred to as echinococcosis. The two
major species of medical and public health importance are Echinococcus granulosus and Echinococcus multilocularis, which cause cystic echinococcosis (CE)3
and alveolar echinococcosis (AE), respectively. Human cystic
echinococcosis is the most common presentation and probably accounts for
>95% of the estimated 3 million global cases, with human alveolar
echinococcosis causing ∼0.3–0.5 million cases (all in the Northern
Hemisphere).The life cycle of the two tapeworms is shown in Fig. 1⇓. Hydatid cysts of E. granulosus
develop in internal organs (mainly liver and lungs) of humans and
intermediate hosts (herbivores such as sheep, horses, cattle, pigs,
goats, and camels) as unilocular fluid-filled bladders. These consist of
two parasite-derived layers, an inner nucleated germinal layer and an
outer acellular laminated layer surrounded by a host-produced fibrous
capsule. Brood capsules and protoscoleces bud off from the germinal
membrane. Definitive hosts are carnivores such as dogs, wolves, and
foxes. Sexual maturity of adult E. granulosus occurs in the
host small intestine within 4–5 wk of ingesting offal containing viable
protoscoleces. Gravid proglottids or released eggs are shed in the feces
and, following their ingestion by a human or ungulate host, an
oncosphere larva is released that penetrates the intestinal epithelium
into the lamina propria. This is then transported passively through
blood or lymph to the target organs where it develops into a hydatid
cyst.
UR - http://www.scopus.com/inward/record.url?scp=58149192462&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=58149192462&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.181.10.6679
DO - 10.4049/jimmunol.181.10.6679
M3 - Short survey
C2 - 18981082
AN - SCOPUS:58149192462
SN - 0022-1767
VL - 181
SP - 6679
EP - 6685
JO - Journal of Immunology
JF - Journal of Immunology
IS - 10
ER -